The Inflation Reduction Act of 2022 has triggered a raft of changes to Medicare Part D plans and Medicare Advantage plans that affect prescription drug coverage in 2025. Here’s what to know.

Follow live updates and news coverage of the Senate confirmation hearing for RFK Jr. Stay up to date with real-time ...

The U.S. Centers for Medicare & Medicaid Services, or CMS, said it is considering ways to bring "greater transparency" to the Medicare drug pricing negotiation program mandated under the Inflation ...

Robert F. Kennedy Jr. said he would follow the Trump administration’s orders on prescription drug price negotiations, a ...

Follow live updates and news coverage of the Senate confirmation hearing for RFK Jr. Stay up to date with real-time ...

More than 65 million Americans rely on the program for their health insurance, with a significant proportion of those being ...

Trump stopped a program that had been in the works and was intended to give Medicare recipients access to more than 100 ...

The price negotiation process was established under former President Joe Biden's signature Inflation Reduction Act in 2022.

A squadron of senators is once again putting forward a proposal to boost price transparency in direct-to-consumer ...

The U.S. Centers for Medicare and Medicaid Services has named Novo Nordisk’s Wegovy, Ozempic and Rybelsus as part of the ...

Once a person buys a Medigap policy, it is guaranteed renewable. With few exceptions, the insurer must renew the policy each ...

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...